Psychedelic Insights From One of the Earliest Researchers - Dr. Charles Grob - HPP 103

For decades, Dr. Charles Grob has been researching applications of MDMA, psilocybin, and ayahuasca for a variety of human conditions including end of life anxiety, PTSD, depression, addiction, and more. His contributions have significantly shaped what we know about psychedelics today and how much of an impact it has on our patients. In today’s episode, we hear about the early challenges in psychedelic research, and learn about Dr. Grob’s perspectives about what elements of a psychedelic-assisted therapy session are essential. We explore the exciting new developments at the intersection between the medical and the spiritual dimensions of healing. Show notes: Early Fascination in Psychedelics - 03:00 Rediscovering Psychedelics - 10:22 Struggling for Approval with The IRB - 14:14 A Look into What Psychedelics Brings - 20:04 Easy Accessibility of Psychedelics in The Future - 25:53 Set and Setting is Critical - 28:35 To learn more about Dr. Charles Grob: https://psychedelicreview.com/person/charles-grob/ https://www.linkedin.com/in/charles-grob-515b369a https://en.wikipedia.org/wiki/Charles_Grob https://www.psychiatryinstitute.com/psychedelic *** How you can help others in a big way... If you enjoy the Higher Practice Podcast, please leave a quick review on the Apple Podcast app. It makes a big difference in getting the word out to other people who will benefit from this podcast. Simply, click on the show on your podcast app>scroll down to the bottom of all the episodes>in the ratings and reviews section tap stars to rate>click write a review. Want more? For show notes and more information, visit https://psychiatryinstitute.com/podcast/ Sign up for our newsletter and to receive ongoing information for optimal mental health: email.psychiatryinstitute.com If you’re a provider visit https://psychiatryinstitute.com/ If you’re interested in patient care visit: www.psychiatrycenters.com For provider education reach out to: [email protected] For patient care reach out to: [email protected]